BioVaxys Technology (BIOV.C) announced today that Immunologist Yvelise Barrios, MD, PhD, has joined the Company as a Scientific Adviser to support development of CoviDTH. Furthermore, studies conducted by Dr….
CoviDTH
BioVaxys Technology (BIOV.C) announced today that the US Food and Drug Administration (FDA) has provided its official Written Response to the Company’s request for a Pre-IND Type B review…